Taxes (Tables)
|
12 Months Ended |
Jun. 30, 2026 |
| Taxes [Abstract] |
|
| Schedule of (Loss) Income Before Income Taxes |
(Loss) income before income taxes and share of (loss) income in equity investees | | | For the year ended June 30 | | | | | 2026 | | | 2025 | | | 2024 | | | Mainland China | | | (7,367,640 | ) | | | 516,640 | | | | 2,878,314 | | | Non-mainland China | | | (4,787,559 | ) | | | (5,592,254 | ) | | | (4,721,679 | ) | | | | | (12,155,199 | ) | | | (5,075,614 | ) | | | (1,843,365 | ) |
|
| Schedule of Statutory Rate to the Company's Effective Tax Rate |
The following table reconciles the statutory rate to the Company’s effective tax rate: | | | For the year ended June 30 | | | | | 2025 | | | 2024 | | | Mainland China statutory income tax rate | | | 25.0 | % | | | 25.0 | % | | Effect of income tax rate difference in other jurisdictions | | | (22.0 | )% | | | (56.5 | )% | | Effect of tax rate changes on deferred taxes | | | 5.3 | % | | | (8.9 | )% | | Effect of mainland China preferential tax rate and tax relief | | | (1.7 | )% | | | (27.0 | )% | | Tax exempt income | | | 1.4 | % | | | 1.6 | % | | Research and development credits | | | 28.2 | % | | | 96.6 | % | | Business insurance | | | (2.5 | )% | | | (5.7 | )% | | Late payment interest | | | (5.0 | )% | | | (20.0 | )% | | Withholding tax | | | - | % | | | (4.7 | )% | | Depreciation and amortization | | | - | % | | | (2.2 | )% | | Investment gain/loss | | | - | % | | | (2.3 | )% | | Statutory income/expense | | | (0.5 | )% | | | 3.9 | % | | Intercompany transfers | | | (14.6 | )% | | | (10.9 | )% | | Change in valuation allowances | | | (30.0 | )% | | | 3.6 | % | | Goodwill impairment | | | (1.3 | )% | | | - | % | | Others | | | (0.9 | )% | | | (1.2 | )% | | Effective tax rate | | | (18.6 | )% | | | (8.7 | )% | | | | As of June 30,2026 | | | | | USD | | | Percent | | | Mainland China statutory income tax rate | | | (3,038,800 | ) | | | 25.0 | % | | Cross border | | | - | | | | - | % | | Change in valuation allowances | | | 2,125,638 | | | | (17.5 | )% | | Nontaxable or nondeductible items | | | 172,726 | | | | (1.4 | )% | | Changes in unrecognized tax benefits | | | (577,077 | ) | | | 4.7 | % | | Foreign tax effects | | | | | | | | | | Singapore | | | | | | | | | | Goodwill impairment | | | 244,083 | | | | (2.0 | )% | | Others | | | 93,246 | | | | (0.8 | )% | | Hong Kong | | | 162,256 | | | | (1.3 | )% | | BVI | | | | | | | | | | Statutory tax rate difference between BVI and China | | | 214,915 | | | | (1.8 | )% | | Cayman | | | | | | | | | | Statutory tax rate difference between Cayman and China | | | 743,375 | | | | (6.1 | )% | | Other foreign jurisdictions | | | (40,318 | ) | | | 0.3 | % | | Other adjustments | | | | | | | | | | Research and development credits | | | (1,530,153 | ) | | | 12.6 | % | | Statutory income/expense | | | 577,077 | | | | (4.7 | )% | | Effect of tax rate changes on deferred taxes | | | (1,222,004 | ) | | | 10.1 | % | | Effect of mainland China preferential tax rate and tax relief | | | 1,238,972 | | | | (10.2 | )% | | Intercompany transfers | | | 739,833 | | | | (6.1 | )% | | Late payment interest | | | 329,931 | | | | (2.7 | )% | | Others | | | (16,761 | ) | | | 0.1 | % | | Income tax expenses | | | 216,939 | | | | (1.8 | )% |
|
| Schedule of Provision (Benefit) for Income Tax |
The provision (benefit) for income tax consists of the following: | | | For the year ended June 30 | | | | | 2026 | | | 2025 | | | 2024 | | | Current income tax | | | 244,336 | | | | 463,191 | | | | 878,404 | | | Deferred income tax | | | (27,397 | ) | | | 484,338 | | | | (717,679 | ) | | Total provision for income tax expenses | | | 216,939 | | | | 947,529 | | | | 160,725 | |
|
| Schedule of Deferred Tax Assets and Liabilities |
The significant components of the deferred tax assets and liabilities are as follows: | | | As of June 30, | | | | | 2026 | | | 2025 | | | Deferred tax assets: | | | | | | | | Net operating loss carry forwards | | | 3,822,774 | | | | 2,188,458 | | | Accrued expenses | | | 13,110 | | | | 36,094 | | | Lease liabilities | | | 531,036 | | | | 840,258 | | | Share of investee’s loss | | | 27,963 | | | | 33,764 | | | Unrealized gains and losses for internal related parties | | | 119,999 | | | | 145,804 | | | Provision for credit losses | | | 665,151 | | | | 168,227 | | | Impairment of deferred contract costs | | | 277,286 | | | | - | | | Others | | | 38,801 | | | | 7,259 | | | Valuation allowances | | | (4,856,865 | ) | | | (2,495,112 | ) | | Total deferred tax assets | | | 639,255 | | | | 924,752 | | | | | | | | | | | | | Deferred tax liabilities: | | | | | | | | | | ROU assets | | | 493,954 | | | | 758,483 | | | Intangible assets | | | 290,210 | | | | 344,139 | | | Total deferred tax liabilities | | | 784,164 | | | | 1,102,622 | | | | | | | | | | | | | Net deferred tax assets | | | 59,691 | | | | 73,942 | | | Net deferred tax liabilities | | | 204,600 | | | | 251,812 | |
|
| Schedule of Unrecognized Tax Benefit |
A reconciliation of the beginning and ending amount of unrecognized tax benefit was as follows: | | | 2026 | | | 2025 | | | 2024 | | | Balance at July 1 | | | 3,880,945 | | | | 2,780,674 | | | | 2,442,085 | | | Increase | | | 1,215,792 | | | | 1,072,205 | | | | 518,179 | | | Decrease | | | (708,484 | ) | | | (15,103 | ) | | | (172,682 | ) | | Foreign currency translation adjustment | | | 216,010 | | | | 43,169 | | | | (6,908 | ) | | Balance at June 30 | | | 4,604,263 | | | | 3,880,945 | | | | 2,780,674 | |
|
| Schedule of Tax Payables |
The Company’s tax payables consist of the following: | | | As of June 30, | | | | | 2026 | | | 2025 | | | | | | | | | | | VAT payable | | | 1,277,802 | | | | 908,992 | | | Corporate income tax payable | | | 372,261 | | | | 113,840 | | | Withholding tax payable | | | 454,699 | | | | 390,640 | | | Disability insurance fund payable | | | 759,004 | | | | 971,516 | | | Other tax payables | | | 97,426 | | | | 78,718 | | | Total tax payables | | | 2,961,192 | | | | 2,463,706 | |
|